{"nct_id":"NCT05201248","title":"A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2022-03-10","start_date_type":"ACTUAL","primary_completion_date":"2025-04","primary_completion_date_type":"ESTIMATED","completion_date":"2025-04","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["GMAB"]}